Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies.
Description | Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies. |
Synonyms | PAZ 417, PAZ-417, PAZ417 |
Molecular Weight | 425.52 |
Formula | C28H27NO3 |
CAS No. | 481629-87-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 245 mg/mL (575.77 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aleplasinin 481629-87-2 代谢 PAI-1 Plasminogen activator inhibitor-1 Serpin family Abeta Inhibitor Alzheimer's disease BBB-penetrated PAZ 417 β-amyloid peptide PAZ417 orally active PAZ-417 memory deficiency Amyloid-β inhibit inhibitor